IL6 and colorectal carcinoma: In contrast, a separate study involving 208 CRC patients across stages I–IV reported that serum IL-6 concentrations were significantly higher in individuals with stage III and IV disease compared to those with earlier-stage CRC (Belluco et al., 2000).